Drug Type Small molecule drug |
Synonyms RAY 0221, RAY0221 |
Target |
Action agonists, stimulants |
Mechanism GCGR agonists(Glucagon receptor agonists), GIP stimulants(Gastric inhibitory polypeptide stimulants), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus | Preclinical | China | 10 Jun 2024 | |
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | China | 10 Jun 2024 | |
| Obesity | Preclinical | China | 10 Jun 2024 |





